Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HQG5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 102 | 104 | PF00675 | 0.691 |
CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.669 |
CLV_NRD_NRD_1 | 169 | 171 | PF00675 | 0.584 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.669 |
CLV_PCSK_SKI1_1 | 175 | 179 | PF00082 | 0.609 |
CLV_PCSK_SKI1_1 | 184 | 188 | PF00082 | 0.525 |
CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.449 |
DOC_MAPK_gen_1 | 148 | 154 | PF00069 | 0.642 |
DOC_MAPK_gen_1 | 90 | 98 | PF00069 | 0.626 |
DOC_PP4_FxxP_1 | 154 | 157 | PF00568 | 0.572 |
DOC_PP4_FxxP_1 | 76 | 79 | PF00568 | 0.677 |
DOC_USP7_MATH_1 | 22 | 26 | PF00917 | 0.704 |
DOC_USP7_MATH_1 | 79 | 83 | PF00917 | 0.680 |
LIG_14-3-3_CanoR_1 | 103 | 109 | PF00244 | 0.660 |
LIG_14-3-3_CanoR_1 | 122 | 126 | PF00244 | 0.626 |
LIG_14-3-3_CanoR_1 | 184 | 192 | PF00244 | 0.608 |
LIG_14-3-3_CanoR_1 | 23 | 27 | PF00244 | 0.597 |
LIG_14-3-3_CanoR_1 | 71 | 77 | PF00244 | 0.566 |
LIG_Actin_WH2_2 | 55 | 73 | PF00022 | 0.638 |
LIG_APCC_ABBA_1 | 56 | 61 | PF00400 | 0.594 |
LIG_APCC_ABBAyCdc20_2 | 55 | 61 | PF00400 | 0.574 |
LIG_BH_BH3_1 | 35 | 51 | PF00452 | 0.631 |
LIG_BRCT_BRCA1_1 | 182 | 186 | PF00533 | 0.630 |
LIG_deltaCOP1_diTrp_1 | 172 | 178 | PF00928 | 0.571 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.610 |
LIG_FHA_1 | 140 | 146 | PF00498 | 0.599 |
LIG_LIR_Apic_2 | 151 | 157 | PF02991 | 0.579 |
LIG_LIR_Apic_2 | 75 | 79 | PF02991 | 0.678 |
LIG_LIR_Gen_1 | 94 | 99 | PF02991 | 0.565 |
LIG_LIR_Nem_3 | 94 | 98 | PF02991 | 0.582 |
LIG_OCRL_FandH_1 | 88 | 100 | PF00620 | 0.622 |
LIG_SH2_STAP1 | 74 | 78 | PF00017 | 0.679 |
LIG_SH2_STAT3 | 106 | 109 | PF00017 | 0.587 |
LIG_SH2_STAT5 | 106 | 109 | PF00017 | 0.587 |
LIG_SH2_STAT5 | 74 | 77 | PF00017 | 0.621 |
LIG_SUMO_SIM_anti_2 | 28 | 35 | PF11976 | 0.425 |
LIG_SUMO_SIM_par_1 | 28 | 35 | PF11976 | 0.425 |
LIG_UBA3_1 | 165 | 171 | PF00899 | 0.607 |
LIG_WRC_WIRS_1 | 73 | 78 | PF05994 | 0.564 |
MOD_Cter_Amidation | 101 | 104 | PF01082 | 0.694 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.625 |
MOD_GSK3_1 | 176 | 183 | PF00069 | 0.638 |
MOD_NEK2_1 | 121 | 126 | PF00069 | 0.697 |
MOD_NEK2_1 | 31 | 36 | PF00069 | 0.623 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.570 |
MOD_PKA_2 | 121 | 127 | PF00069 | 0.599 |
MOD_PKA_2 | 137 | 143 | PF00069 | 0.677 |
MOD_PKA_2 | 22 | 28 | PF00069 | 0.579 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.582 |
MOD_SUMO_rev_2 | 47 | 57 | PF00179 | 0.662 |
TRG_ER_diArg_1 | 189 | 192 | PF00400 | 0.605 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HYZ7 | Leptomonas seymouri | 86% | 100% |
A0A0S4IQL1 | Bodo saltans | 62% | 100% |
A0A1X0NLH3 | Trypanosomatidae | 69% | 100% |
A0A3R7MH65 | Trypanosoma rangeli | 68% | 100% |
A0A3S7XC64 | Leishmania donovani | 93% | 100% |
A4ICA1 | Leishmania infantum | 93% | 100% |
D0A3L6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 70% | 100% |
E9AU81 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4Q0B3 | Leishmania major | 92% | 100% |